Stay updated on Safety & Efficacy of FG-3019 in IPF Clinical Trial
Sign up to get notified when there's something new on the Safety & Efficacy of FG-3019 in IPF Clinical Trial page.

Latest updates to the Safety & Efficacy of FG-3019 in IPF Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe study locations section was updated to include new sites across the United States, Canada, Australia, India, and South Africa. The page revision was updated to version 3.3.3.SummaryDifference2%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe Publications section text was updated to state that publications are automatically filled from PubMed and may not be about the study, and the Revision label changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedThe government funding/operating status notice was removed from the page. Core study information and trial details remain unchanged.SummaryDifference0.2%

- Check58 days agoChange DetectedResults have been posted on the page, including primary and secondary outcome measures, safety outcomes, and the date of results submission. The page now also lists the study dates and locations related to the results.SummaryDifference0.2%

- Check87 days agoChange DetectedAdded an operating-status notice and link, plus a version bump to v3.2.0; removed the previous v3.1.0 reference.SummaryDifference2%

- Check94 days agoChange DetectedUpdate to version v3.1.0 with removal of several drug-safety topics; indicates content reorganization/rebranding more than new substantive information.SummaryDifference0.2%

Stay in the know with updates to Safety & Efficacy of FG-3019 in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of FG-3019 in IPF Clinical Trial page.